Concentration-dependent effects of transforming growth factor β1 on corneal wound healing

被引:0
作者
Wang, Lingyan [1 ]
Ko, Chun-Ying [1 ]
Meyers, Erin E. [1 ]
Pedroja, Benjamin S. [1 ]
Pelaez, Nadia [1 ]
Bernstein, Audrey M. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA
关键词
IN-SITU KERATOMILEUSIS; TGF-BETA; FIBROBLASTS; CELLS; EXPRESSION; FIBROSIS; KINASE; INJURY; LASIK;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: There is an unmet challenge to promote wound healing in non-healing wounds such as in the post-LASIK (laserassisted in situ keratomileusis) cornea. Using human corneal fibroblasts (HCFs) in cell culture, we investigated the concentration dependence of the growth factor transforming growth factor beta 1 (TGF beta 1) on wound closure. Although high concentrations of TGF beta 1 leads to scarring, we asked whether low concentrations of TGF beta 1 could promote wound healing without generating a large fibrotic response. Methods: HCFs were cultured in supplemented serum-free media (SSFM). Cell migration was assessed by scratchwounding. SMAD 2/3 and p38 mitogen-activated protein kinase (p38MAPK) localization and a-smooth muscle actin (a-SMA) organization were evaluated by immunocytochemistry. Active TGF beta was quantified using a luciferase bio-assay. Results: We found that neutralizing antibody to TGF beta 1 reduced cell migration by 73%, compared to immunoglobulin G (IgG) control, establishing that endogenous TGF beta 1 (determined to be 0.01 ng/ml) is necessary to promote cell migration. To evaluate the concentration-dependent effects of TGF beta 1 on wound closure, HCF migration was quantified to determine the impact of increasing concentrations of TGF beta 1 (0.01-1.0 ng/ml). Compared to control (cells in SSFM), the higher concentrations (0.1 and 1.0 ng/ml TGF beta 1) significantly decreased cell migration (63%-86%), induced myofibroblast differentiation (83%-88%), increased SMAD 2/3 localization into the nucleus (72%-79%) and inhibited the activation of p38MAPK (51%-63%). In contrast, addition of the lower concentration of TGF beta 1 (0.01 ng/ml TGF beta 1) promoted a cell migration rate that was similar to endogenous TGF beta, reduced SMAD 2/3 nuclear localization, and stimulated p38MAPK activation. A TGF beta 1 blocking antibody and the p38MAPK inhibitor, SB202192, was used to demonstrate that p38MAPK activation is necessary for TGF beta 1-induced cell migration. Conclusions: Together, our data demonstrate that low concentrations of TGF beta 1 promote p38MAPK activation that is a key to HCF migration, suggesting that a low concentration of TGF beta may be useful in treating non-healing corneal wounds.
引用
收藏
页码:2835 / 2846
页数:12
相关论文
共 28 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   Corneal myofibroblast generation from bone marrow-derived cells [J].
Barbosa, Flavia L. ;
Chaurasia, Shyam S. ;
Cutler, Alicia ;
Asosingh, Kewal ;
Kaur, Harmet ;
de Medeiros, Fabricio W. ;
Agrawal, Vandana ;
Wilson, Steven E. .
EXPERIMENTAL EYE RESEARCH, 2010, 91 (01) :92-96
[3]   Urokinase anchors uPAR to the actin cytoskeleton [J].
Bernstein, AM ;
Greenberg, RS ;
Taliana, L ;
Masur, SK .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (09) :2967-2977
[4]   Differential regulation of key stages in early corneal wound healing by TGF-β Isoforms and their inhibitors [J].
Carrington, Louise M. ;
Albon, Julie ;
Anderson, Ian ;
Kamma, Christina ;
Boulton, Mike .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (05) :1886-1894
[5]   Interface fluid syndrome in human eye bank corneas after LASIK - Causes and pathogenesis [J].
Dawson, Daniel G. ;
Schmack, Ingo ;
Holley, Glenn P. ;
Waring, George O., III ;
Grossniklaus, Hans E. ;
Edelhauser, Henry F. .
OPHTHALMOLOGY, 2007, 114 (10) :1848-1859
[6]   Histologic, ultrastructural, and immuno fluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds [J].
Dawson, DG ;
Kramer, TR ;
Grossniklaus, HE ;
Waring, GO ;
Edelhauser, HF .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (06) :741-756
[7]   Corneal keratocyte deficits after photorefractive keratectomy and laser in situ keratomileusis [J].
Erie, JC ;
Patel, SV ;
McLaren, JW ;
Hodge, DO ;
Bourne, WM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 141 (05) :799-809
[8]   The molecular basis of corneal transparency [J].
Hassell, John R. ;
Birk, David E. .
EXPERIMENTAL EYE RESEARCH, 2010, 91 (03) :326-335
[9]  
Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78
[10]   SB-431542 is a potent and specific inhibitor of transforming growth factor-β superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 [J].
Inman, GJ ;
Nicolás, FJ ;
Callahan, JF ;
Harling, JD ;
Gaster, LM ;
Reith, AD ;
Laping, NJ ;
Hill, CS .
MOLECULAR PHARMACOLOGY, 2002, 62 (01) :65-74